Publications | Goodwin Bio

Goodwin Biotechnology, Inc. Uniquely Meets the Contract Development and Manufacturing Needs for Today’s Complex, Targeted Biopharmaceuticals CEOCFO Magazine

PDF (158.31 KB)

Powerful New High Pressure Pump Speeds Up Virus Filtration and Concentration Process; February, 2019

External Link

Goodwin Biotechnology named “Biologics cGMP Manufacturer of the Year 2018” Global Health & Pharma – Biotechnology Awards 2018

PDF (279.29 KB)

Early Phase Development Considerations of Antibody-Payload Conjugates. Sesay M. and Fang C. Presentation at the World ADC Conference San Diego November, 18th 2018.

PDF (1.22 MB)

A Radiolabeled Fully Human Antibody to Human Aspartyl (Asparaginyl) b-Hydroxylase Is a Promising Agent for Imaging and Therapy of Metastatic Breast Cancer – Ekaterina Revskaya, Zewei Jiang, Alfred Morgenstern, Frank Bruchertseifer, Muctarr Sesay et al; Cancer Biotherapy and Radiopharmaceuticals vol 32, #2, 2017 pg 75

PDF (689.97 KB)

Developing Antibody Drug Conjugates (ADCs) with Site-Directed Conjugation. Poster Presentation at the 8th Annual World ADC Meeting by Sesay M and Cunningham D. September 2017

PDF (6.51 MB)

Optimizing a Unique Cancer Vaccine for Intradermal Delivery; Steven Fuller, Mark Tomai, John Price, Muctarr Sesay, Dave Cunningham; BioPharm International, September 2017

PDF (515.05 KB)

Humanization of JA-F11, a highly specific anti-Thomsen-Friedenreich pancarcinoma antibody and in vitro efficacy analysis. Tati S, Fisk JC, Abdullah J, et al. Neoplasia. 19 (9); 716-733: 2017

PDF (2.40 MB)

Q&A with Karl Pinto, CEO of Goodwin Biotechnology, Inc. a Contract Development and Manufacturing Organization helping Biotechnology Companies take their Biologics from Lab to the Clinic CEOCFO Magazine, August 28, 2017

PDF (211.49 KB)

Reducing Clinical-Phase Manufacturing Costs. Pentia D, Gonzalez-Perez M, Fabiano A, Peyser JR, Vicalvi J, Sesay M, and Tingley S. BioProcess International; 2016; 14(11): 44-53

External Link

1 2